Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vaginal bromocriptine for symptomatic adenomyosis
ACTRN12617001122347Phase 4Not yet recruiting
- Sponsor
- Nahed ezzat allam
- Start
- Feb 2019
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, randomised trial of bromocriptine in adenomyosis, sponsored by Nahed ezzat allam. Planned start Feb 2019; status: not yet recruiting.
02
Drugs
bromocriptine
03
Conditions
adenomyosis
Beyond the preview
Go deeper on ACTRN12617001122347.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ACTRN12617001122347.